医学
肺活量测定
慢性阻塞性肺病
哮喘
肺活量
通风(建筑)
内科学
心脏病学
肺功能测试
肺
肺功能
扩散能力
机械工程
工程类
作者
Laurie Smith,Helen Marshall,Demi Jakymelen,Alberto Biancardi,Guilhem Collier,Ho‐Fung Chan,Paul Hughes,Martin L Brook,Joshua Astley,Ryan Munro,Smitha Rajaram,Andrew J. Swift,David Capener,Jody Bray,James Ball,Oliver Rodgers,Bilal Tahir,Madhwesha Rao,Graham Norquay,Nicholas Weatherley
出处
期刊:Thorax
[BMJ]
日期:2025-05-27
卷期号:80 (12): 909-917
被引量:2
标识
DOI:10.1136/thorax-2024-222347
摘要
RATIONALE: Airways dysanapsis is defined by CT or spirometry as a mismatch between the size of the airways and lung volume and is associated with increased risk of developing chronic obstructive pulmonary disease (COPD). Lung disease in participants with dysanapsis and a label of asthma and/or COPD remains poorly understood. METHODS: Xe-MRI to assess ventilation, acinar dimensions and gas exchange, and pulmonary function tests, and compared people with spirometric dysanapsis (forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC)<-1.64 z and FEV1>-1.64 z) to those with normal spirometry (FEV1, FVC and FEV1/FVC>-1.64 z). RESULTS: =0.38, p<0.001), with the highest values seen in those with an FVC above the upper limit of normal. CONCLUSIONS: Xe-MRI, when compared with those with normal spirometry. Spirometric dysanapsis in asthma and/or COPD is therefore associated with significant lung disease, and the FEV1/FVC is related to the degree of airways abnormality on 129Xe-MRI.
科研通智能强力驱动
Strongly Powered by AbleSci AI